Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Hagit Kopel, Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Isabelle Winer, Thierry Ducruet, Ni Zeng, Mac Bonafede, Daina B. Esposito, David Martin, Andrew Rosen, Nicolas Van de Velde, Sten H. Vermund, Stefan Gravenstein, James A. Mansi
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2023-11-01
Serier:	Vaccines
Fag:	mRNA-1273.222 BNT162b2 Bivalent vaccine bivalent vaccine COVID-19 vaccine hospitalization symptomatic disease
Online adgang:	https://www.mdpi.com/2076-393X/11/11/1711
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!